期刊文献+

焦虑、抑郁情绪对2型糖尿病疗效的影响 被引量:17

Comparative study on effect of anxiety or depression on the therapeutic efficacy in type 2 diabetes
下载PDF
导出
摘要 目的:探讨焦虑、抑郁情绪对2型糖尿病患者疗效的影响。方法:136例糖尿病患者治疗前根据抑郁自评量表(SDS)或焦虑自评量表(SAS)评分后分为焦虑、抑郁组64例(SDS或SAS≥50分)和对照组72例(SDS或SAS<50分);两组均给予胰岛素治疗1个月。于治疗前后进行空腹血糖(FBG)、餐后2h血糖(2hBG)、糖化血红蛋白(HbA1c)、超敏C-反应蛋白(hsC-RP)及SDS、SAS评分比较。结果:虽经胰岛素系统治疗,但伴有焦虑、抑郁情绪的糖尿病患者的FBG、2hBG及hsC-RP水平仍明显高于对照组(P<0.05或P<0.01);胰岛素用量更多,血糖控制更难达标。结论:焦虑、抑郁情绪严重影响糖尿病的治疗与转归。 Objective:To investigate the effect of anxiety and depression on the therapeutic efficacy in type 2 diabetes(T2DM).Method:According to self rating depressive scale(SDS)and self rating anxiety scale(SAS),136 T2DM patients were divided into study group(scores of SAS or SDS≥50,64cases),and control group (scores of SAS or SDS50,72cases)before treatment.Both of two groups of patients were given insulin therapy for a month and the dosage of insulin was recorded.Fasting blood glucose(FBG),2-hour post prandial blood glucose(2 hBG),glucoted hemoglobin(HbA1c),and high sensitivity C-reactive protein(hsC-RP)were compared before and after treatment,as well as scores of SAS and SDS,which were re-scored after treatment.Results:The existence of anxiety and depression in T2DM patients results in significant higher C-RP level and blood glucose level.These patients need more insulin to control their blood glucose.Conclusion:Anxiety,depression and other negative emotion seriously influence the treatment effect and prognosis of type 2 diabetes.
作者 高常涛
出处 《临床精神医学杂志》 2010年第3期190-191,共2页 Journal of Clinical Psychiatry
关键词 焦虑 抑郁 糖尿病 anxiety depression diabetes
  • 相关文献

参考文献3

二级参考文献11

  • 1Koenig W,Sund M,Frohlich M,et al.C-Reactive protein,a sensitive marker of inflammation,predicts future risk of coronary heart disease in initially healthy middle-aged men:results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Diseas
  • 2Spranger J,Kroke A,Mohlig M,et al.Inflammatory cytokines and the risk to develop type 2 diabetes:results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study.Diabetes,2003,52(3):812-817.
  • 3Yudkin JS,Panahloo A,Stehouwer C,et al.The influence of improved glycaemic control with insulin and sulphonylureas on acute phase and endothelial markers in Type II diabetic subjects.Diabetologia,2000,43(9):1099-1106.
  • 4Volanakis JE.Human C-reactive protein:expression,structure,and function.Mol Immunol,2001,38(2-3):189-197.
  • 5Ford ES.Body mass index,diabetes,and C-reactive protein among U.S.adults.Diabetes Care,1999,22(12):1971-1977.
  • 6Pradhan AD,Manson JE,Rifai N,et al.C-reactive protein,interleukin 6,and risk of developing type 2 diabetes mellitus.JAMA,2001,286(3):327-334.
  • 7Taniguchi A,Nagasaka S,Fukushima M,et al.C-reactive protein and insulin resistance in non-obese Japanese type 2 diabetic patients.Metabolism,2002,51(12):1578-1581.
  • 8Colwell GA.Inflammation and diabetic vascular complications.Diabetes Care,1999,22(12):1927-1928.
  • 9Woodman RJ,Watts GF,Puddey IB,et al.Leukocyte count and vascular function in Type 2 diabetic subjects with treated hypertension.Atherosclerosis,2002,163(1):175-181.
  • 10Mojiminiyi OA,Abdella N,Moussa MA,et al.Association of C-reactive protein with coronary heart disease risk factors in patients with type 2 diabetes mellitus.Diabetes Res Clin Pract,2002,58(1):37-44.

共引文献81

同被引文献165

引证文献17

二级引证文献90

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部